Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children

Pediatric Radiology

Volumn 35, Issue 5, 2005, Pages 501-510

  Colosimo, Cesare ^a   Demaerel, Philippe ^b   Tortori Donati, Paolo ^c   Christophe, Catherine ^d   Van Buchem, Mark ^e   Högström, Barry ^f   Pirovano, Gianpaolo ^f   Shen, Ningyan ^f   Kirchin, Miles A ^g   Spinazzi, Alberto ^f  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c G GASLINI INSTITUTE   (Italy)

^d HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Bracco Research USA   (United States)

^g Bracco Imaging SpA   (Italy)

Author keywords

Brain; Contrast media; Gd DTPA; MRI; Spine; Tumours

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BRAIN SCINTISCANNING; BRAIN TUMOR; CHILD; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE PAIN; FEMALE; FEVER; HUMAN; IMAGE ANALYSIS; INFANT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PAPULE; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIGNAL NOISE RATIO; SPINE TUMOR; SWEATING; TUMOR LOCALIZATION; VOMITING;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DOUBLE-BLIND METHOD; GADOLINIUM; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; MAGNETIC RESONANCE IMAGING; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SAFETY; SPINAL NEOPLASMS;

EID: 23844529205     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-004-1392-4     Document Type: Article

References (42)

1. Han JS, Benson JE, Kaufman B, et al (1985) MR imaging of pediatric cerebral abnormalities. J Comput Assist Tomogr 9:103-114
2. Kucharczyk W, Brant-Zawadzki M, Sobel D, et al (1985) Central nervous system tumors in children: Detection by magnetic resonance imaging. Radiology 155:131-136
3. Baierl P, Muhlsteffen A, Haustein J, et al (1990) Comparison of plain and Gd-DTPA-enhanced MR-imaging in children. Pediatr Radiol 20:515-519
4. Ge HL, Hirsch WL, Wolf GL, et al (1992) Diagnostic role of gadolinium-DTPA in pediatric neuroradiology. A retrospective review of 655 cases. Neuroradiology 34:122-125 10.1007/BF00588157
5. Kollias SS, Barkovich AJ, Edwards MS (1991-1992) Magnetic resonance analysis of suprasellar tumors of childhood. Pediatr Neurosurg 17:284-303
6. Bronen RA, Sze G (1990) Magnetic resonance imaging contrast agents: theory and application to the central nervous system. J Neurosurg 73:820-839
7. Atlas SW (1993) Rationale and clinical indications for contrast agents in MR imaging of the brain and spine. J Comput Assist Tomogr 17[Suppl 1]:S1-7
8. de Haën C, Cabrini M, Akhnana L, et al (1999) Gadobenate dimeglumine 0.5 M solution for injection (MultiHance®): pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23[Suppl 1]:S161-S168
9. Haustein J, Laniado M, Niendorf H-P, et al (1992) Administration of gadopentetate dimeglumine in MR imaging of intracranial tumors: Dosage and field strength. AJNR 13:1199-1206
10. Yuh WT, Fisher DJ, Engelken JD, et al (1991) MR evaluation of CNS tumors: Dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 180:485-491
11. Myhr G, Rinck PA, Børseth A (1992) Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS. Acta Radiol 33:405-409
12. Balériaux D, Matos C, De Greef D (1993) Gadodiamide injection as a contrast medium for MRI of the central nervous system: A comparison with gadolinium-DOTA. Neuroradiology 35:490-494 10.1007/BF00588702
13. Valk J, Algra PR, Hazenberg CJ, et al (1993) A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system. Neuroradiology 35:173-177 10.1007/BF00588486
14. Brugières P, Gaston A, Degryse HR, et al (1994) Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA). Neuroradiology 36:27-30 10.1007/BF00599189
15. Åkeson P, Jonsson E, Haugen I, et al (1995) Contrast-enhanced MRI of the central nervous system: Comparison between gadodiamide injection and gadolinium-DTPA. Neuroradiology 37:229-233 10.1007/s002340050079
16. Oudkerk M, Sijens PE, van Beek EJ, et al (1995) Safety and efficacy of Dotarem (Gd-DOTA) versus Magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system. Invest Radiol 30:75-78
17. Grossman RI, Rubin DI, Hunter G, et al (2000) Magnetic resonance imaging in patients with central nervous system pathology. A comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). Invest Radiol 35:412-419 10.1097/00004424-200007000-00003
18. Greco A, Parker JR, Ratcliffe CG, et al (2001) Phase III, randomized, double blind, crossover comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions. Australas Radiol 45:457-463 10.1046/j.1440-1673.2001.00957.x
19. Cavagna FM, Maggioni F, Castelli PM, et al (1997) Gadolinium chelates with weak binding to serum proteins. Invest Radiol 32:780-796 10.1097/ 00004424-199712000-00009
20. Colosimo C, Ruscalleda J, Korves M, et al (2001) Detection of intracranial metastases: A multi-center, intra-patient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dose. Invest Radiol 36:72-81 10.1097/00004424-200102000-00002
21. Runge VM, Armstrong MR, Barr RG, et al (2001) A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology. Invest Radiol 36:65-71 10.1097/ 00004424-200102000-00001
22. Runge V, Parker JR, Donovan M (2002) Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain. Invest Radiol 37:269-280 10.1097/00004424-200205000-00005
23. Knopp MV, Runge VM, Essig M, et al (2004) Primary and secondary brain tumors at MR imaging: Bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine. Radiology 230:55-64
24. Colosimo C, Knopp MV, Barreau X, et al (2004) Is increased relaxivity beneficial for contrast-enhanced MR imaging of brain tumors? Blinded intraindividual comparison of Gd-BOPTA and Gd-DOTA. Neuroradiology 46:655-665 10.1007/s00234-003-1128-4
25. La Noce A, Baldoli C, D'Incerti L, et al (2000) Safety and efficacy of gadobenate dimeglumine in MR imaging of pediatric CNS. Comparison with gadopentetate dimeglumine. Proc Int Soc Mag Reson Med 8:2032 (abstract)
26. Fitz C (1993) Magnetic resonance imaging of pediatric brain tumors. Top Magn Reson Imaging. 5:174-189
27. YL Young HW Heise E Silverberg 1978 Cancer incidence, survival and mortality for children under 15 years of age American Cancer Society New York
28. Tadmor R, Harwood-Nash DC, Scotti G, et al (1982) Intracranial neoplasms in children: The effect of computed tomography on age distribution. Radiology 145:371-373
29. Farwell JR, Dohrmann GJ, Flannery JT (1977) Central nervous system tumors in children. Cancer 40:3123-3132
30. Amador LV (1983) Brain tumors in the young. Charles C. Thomas, Springfield, Ill
31. Naidich TP, Zimmermann RA (1984) Primary brain tumors in children. Semin Roentgenol 19:100-114
32. Davis DO (1997) CT in the diagnosis of supratentorial tumors. Semin Roentgenol 12:97-108
33. RE Behrmann RM Kliegman HB Jenson 2000 Nelson textbook of pediatrics, 16th edn Saunders Philadelphia
34. DS Russell LJ Rubinstein 1989 Pathology of tumors of the nervous system William and Wilkins Baltimore
35. Fitz CR (1985) In: Gonzales CF, Grossman CB, Masdeu JC (eds) Head and spine imaging. Wiley, New York, pp 385-410
36. Mahaley MS, Mettlin C, Natarajan N, et al (1989) National survey of patterns of care for brain tumor patients. J Neurosurg 71:826-836
37. Surawicz TS, Davis F, Freels S, et al (1998) Brain tumor survival: results from the national cancer data base. J Neurooncol 40:151-160 10.1023/A:1006091608586
38. Ulrich NJ, Pomeroy SL (2003) Pediatric brain tumors. Neurol Clin 21:897-913
39. Sklar CA (2002) Childhood brain tumors. J Pediatr Endocrinol Metab 15:669-673
40. Tomita T (1992) Long-term effects of treatment for childhood brain tumors. Neurosurg Clin N Am 4:959-971
41. La Marca F, Tomita T (1997) Importance of patient evaluation for long-term survival in medulloblastoma recurrence. Childs Nerv Syst 13:30-34 10.1007/s003810050035
42. Elster AD, Rieser GD (1989) Gd-DTPA-enhanced cranial MR imaging in children: Initial clinical experience and recommendations for its use. AJR 153:1265-1268